Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,559Revenue (TTM) $M169Net Margin (%)-83.1Altman Z-Score79.4
Enterprise Value $M5,080EPS (TTM) $-1.3Operating Margin %-84.4Piotroski F-Score6
P/E(ttm)--Beneish M-Score-0.8Pre-tax Margin (%)-83.1Higher ROA y-yY
Price/Book9.610-y EBITDA Growth Rate %18.6Quick Ratio16.4Cash flow > EarningsY
Price/Sales30.45-y EBITDA Growth Rate %24.5Current Ratio16.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-35.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-39.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M119ROIC % (ttm)-373.8Gross Margin Increase y-yY

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

EXAS is held by these investors:



EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIDGARD GRAHAM PETERChief Science Officer 2017-10-02Sell81,025$47.16-1.02view
COWARD D SCOTTSVP and General Counsel 2017-10-02Sell29,115$47.16-1.02view
LIDGARD GRAHAM PETERChief Science Officer 2017-09-05Sell75,683$40.8114.38view
LIDGARD GRAHAM PETERChief Science Officer 2017-09-01Sell45,775$41.4912.51view
Carey Thomas D.Director 2017-08-17Buy2,500$37.7123.79view
Elliott Jeffrey ThomasCFO 2017-07-31Sell5,846$39.4118.45view
COWARD D SCOTTSVP and General Counsel 2017-07-03Sell1,987$35.2132.58view
COWARD D SCOTTSVP and General Counsel 2017-04-03Sell1,543$23.7496.63view
LIDGARD GRAHAM PETERChief Science Officer 2017-03-13Sell2,945$21.16120.6view
COWARD D SCOTTSVP and General Counsel 2017-03-13Sell1,983$21.16120.6view

Press Releases about EXAS :

Quarterly/Annual Reports about EXAS:

News about EXAS:

Articles On GuruFocus.com
Exact Sciences schedules third-quarter 2017 earnings call Oct 10 2017 
Exact Sciences to participate in Baird Global Healthcare Conference Aug 30 2017 
Exact Sciences to participate in Canaccord Genuity Growth Conference Aug 01 2017 
Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent f Jul 25 2017 
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees Jul 21 2017 
Exact Sciences to host second-quarter 2017 results, annual meeting webcasts and calls Jul 10 2017 
Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening Jun 22 2017 
Exact Sciences Announces Pricing of Public Offering of Common Stock Jun 07 2017 
Exact Sciences Announces Agreement to Sell 7,000,000 Common Shares Jun 06 2017 
Exact Sciences to participate in June investor conferences Jun 01 2017 

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK